UnitedHealth Group (NYSE:UNH) Issues Earnings Results

UnitedHealth Group (NYSE:UNH) announced its quarterly earnings results on Tuesday. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.14 by $0.55, reports. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. During the same quarter in the prior year, the business earned $2.59 earnings per share.

UnitedHealth Group Trading Down 0.3%

NYSE:UNH opened at $377.98 on Tuesday. The stock has a fifty day simple moving average of $388.03 and a 200 day simple moving average of $381.81. The firm has a market capitalization of $339.27 billion, a price-to-earnings ratio of 24.32, a price-to-earnings-growth ratio of 1.43 and a beta of 0.60. UnitedHealth Group has a 1-year low of $255.96 and a 1-year high of $461.62. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.66.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were issued a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, September 14th. UnitedHealth Group’s dividend payout ratio is currently 59.72%.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth reported adjusted third-quarter earnings of $4.69 per share, ahead of the $4.12 analyst consensus and up from $2.92 a year earlier. Reported net income was $4.11 billion, or $4.56 per share, compared with $2.35 billion, or $2.59 per share, in the prior-year quarter. UnitedHealth Group Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: The company raised its full-year 2026 earnings outlook to approximately $19.50-$20.00 per share, signaling greater confidence in profitability and supporting the stock’s rally. UnitedHealth Group tops estimates and hikes profit outlook
• Positive Sentiment: Medical-cost management showed improvement, a key issue for health insurers. UnitedHealth also cited progress from value-based care and artificial-intelligence investments, suggesting potential support for longer-term margins and efficiency. UnitedHealth Earnings Beat Wall Street Estimates
• Neutral Sentiment: Optum Health revenue declined, creating a potential constraint on overall growth even as the company delivered better earnings and raised guidance. Investors are likely to watch whether improved margins can offset weaker top-line performance. UnitedHealth raises guidance as Optum Health revenue slips

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on UNH. Zacks Research cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Monday, September 14th. BMO Capital Markets set a $512.00 target price on shares of UnitedHealth Group in a research note on Tuesday, July 21st. Raymond James Financial upped their target price on shares of UnitedHealth Group from $370.00 to $460.00 and gave the stock an “outperform” rating in a research report on Tuesday, July 14th. Barclays lifted their price target on UnitedHealth Group from $429.00 to $441.00 and gave the company an “overweight” rating in a report on Monday, July 20th. Finally, TD Cowen reduced their price objective on UnitedHealth Group from $430.00 to $402.00 and set a “hold” rating for the company in a research report on Friday. Twenty analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $462.59.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the company’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.19% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.